Navigation Links
Dr. Blair Keagy Launches MPAnalytics, Inc. Medical Consultant Group : MPAnalytics, a Medical Consultant Group, Provides Market Analysis and Guidance for New Medical Devices, Technology, and Clinical Trial Protocol
Date:11/17/2008

Blair Keagy, MD, CEO, is pleased to announce the launch of MPAnalytics, Inc. - a medical consultant group dedicated to helping businesses evaluate the commercial potential of new medical products and technologies.

CHAPEL HILL, N.C. (Business Wire EON) November 17, 2008 -- MPAnalytics provides market analysis and recommendations for new medical devices and technology based on five key parameters: scientific merit, reimbursement potential, competition and clinical potential, practical market potential and clinical trial analysis. The founders of MPAnalytics have extensive clinical experience as well as knowledge of clinical trial design, reimbursement issues and practical markets for new medical devices and technologies.

  • Blair Keagy, former Chief of Vascular Surgery at the University of North Carolina, has authored numerous articles as well as a textbook on healthcare economics and is considered an expert on medical reimbursement.

"I credit my colleagues at the UNC School of Medicine and the Kenan-Flaghler Launching the Venture Program with helping to get this business off the ground," states Dr. Keagy. "Now, we have clients enthusiastically soliciting our help in assessing the business potential of their new medical devices or ideas before investing significant monies in development or clinical trial."

  • Zoller, Executive Director, UNC Center for Entrepreneurial Studies describes MPAnalytics as "an excellent example of the type of entrepreneurial venture that we hope will emerge from our program. Blair and his team have great medical expertise. MPA's assessment of commercial potential and their depth of market
    '/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Page: 1 2

Related medicine news :

1. Cardica to Present at William Blair Small-Cap Growth Stock Conference
2. Covance to Present at the William Blair Growth Stock Conference
3. VNUS Medical Technologies to Present at William Blair & Companys 28th Annual Growth Stock Conference
4. WebMD to Present at the William Blair 28th Annual Growth Stock Conference
5. Insulet Corporation to Present at the William Blair & Company 28th Annual Growth Stock Conference on June 19, 2008
6. Medco to Present at the William Blair & Company, L.L.C. 28th Annual Growth Conference
7. SAIC to Webcast Presentation at William Blair Growth Stock Conference
8. IDEXX Laboratories to Present at William Blair 28th Annual Growth Stock Conference
9. VNUS Medical Technologies Presents at William Blair Small-Cap Growth Stock Conference
10. Presentation Time Correction: Keryx Biopharmaceuticals Presents at 12:00pm, ET Tomorrow (Oct. 3) at William Blair & Company Small-Cap Growth Stock Conference
11. iCAD to Present at William Blair & Company Small-Cap Growth Stock Conference
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
 Dr. Blair Keagy Launches MPAnalytics, Inc. Medical Consultant Group :  MPAnalytics, a Medical Consultant Group, Provides Market Analysis and Guidance for New Medical Devices, Technology, and Clinical Trial Protocol 
(Date:8/2/2014)... According to the Girl Gets Ring System review ... for women. The book consists of dating tips and tricks ... book also teaches women how to deal with relationship ... its review that this book is divided into 10 chapters ... Story? ,     Chapter 2 – How A Traffic Light ...
(Date:8/2/2014)... On July 21, 2014, the Johns Hopkins Health ... settle the class action lawsuit filed October 24, ... 24-C-13-001041 MM, on behalf of thousands of women who allegedly ... According to The Baltimore Sun , the $190 ... a physician accused of sexual misconduct. , An investigation prompted ...
(Date:8/1/2014)... The successful development of C60F projects is of ... Automobile Co.,LTD. As early as the very beginning of ... excellent team to develop a comprehensive plan to carry ... The company’s vice president Liming Yang and some of ... the specific arrangement and the supervision of the project ...
(Date:8/1/2014)... of Medicine in St. Louis helps explain why brain ... more harmful than similar tumors in females. For example, ... twice as often in males, who suffer greater cognitive ... , The researchers found that retinoblastoma protein (RB), a ... active in male brain cells than in female brain ...
(Date:8/1/2014)... (HealthDay News) -- The U.S. Food and Drug Administration ... Jardiance, to help fight type 2 diabetes. ... existing treatment regimens to control blood sugar levels in ... of the Office of Drug Evaluation II in the ... an agency statement. The FDA also recommended that ...
Breaking Medicine News(10 mins):Health News:Girl Gets Ring System Review Exposes Jonathan Green's Dating Guide For Women – Vkool.com 2Health News:Girl Gets Ring System Review Exposes Jonathan Green's Dating Guide For Women – Vkool.com 3Health News:Baltimore Lawyer Steven H. Heisler Urges Victims of OB/GYN Misconduct to Speak Out 2Health News:Baltimore Lawyer Steven H. Heisler Urges Victims of OB/GYN Misconduct to Speak Out 3Health News:FODAY Automobile Company Is Now Working On The C60F FODAY Project 2Health News:Study reveals one reason brain tumors are more common in men 2Health News:FDA Approves New Type 2 Diabetes Drug 2
... House ceremony next month, Thomas L. Kash, PhD, assistant professor ... for Alcohol Studies at the University of North Carolina at ... Career Award for Scientists and Engineers (PECASE). , This is ... science and engineering professionals in the early stages of their ...
... in the October 2011 issue of The FASEB ... "healthy" ingredient in red wine, stops breast cancer cells ... This discovery, made by a team of American and ... is able to counteract the malignant progression since it ...
... By Serena Gordon HealthDay Reporter , WEDNESDAY, Sept. 28 ... advanced Alzheimer,s or other form of severe dementia will be shuttled ... months of life, a new U.S. study shows. The ... Depending on where a patient lives, as many as ...
... the British Journal of Sports Medicine * highlights the injury ... chance of a school player suffering an injury during a single ... research, could be as high as 90 per cent. The ... City University say there is an urgent need to inform children, ...
... with dementia can still make decisions in their everyday lives ... as their condition advances. This is one of the preliminary ... and Social Research Council (ESRC) into how married couples living ... study is investigating how couples make decisions over issues such ...
... dose of the hallucinogen psilocybin, the active ingredient in ... measureable personality change lasting at least a year in ... new study, according to the Johns Hopkins researchers who ... part of the personality known as openness, which includes ...
Cached Medicine News:Health News:UNC researcher to receive highest US honor for early career science professionals 2Health News:End-Stage Alzheimer's Patients Often Hospitalized Unnecessarily 2Health News:End-Stage Alzheimer's Patients Often Hospitalized Unnecessarily 3Health News:Academic issues warning on schoolboy rugby 2Health News:Living with dementia and making decisions 2Health News:Single dose of hallucinogen may create lasting personality change 2Health News:Single dose of hallucinogen may create lasting personality change 3
(Date:7/31/2014)... , July 31, 2014  Sorrento Therapeutics, Inc. (NASDAQ: ... Mr. Amar Singh , Chief Business Officer and Executive ... natural causes on July 30. "Sorrento is deeply ... and colleague. Our immediate thoughts go to Amar,s family and ... Chief Executive Officer. Mr. Singh joined Sorrento ...
(Date:7/31/2014)... Diabetes Care®, Inc. (NASDAQ: TNDM ), a medical ... reported its financial results for the quarter ended June 30, ... 2014 to the same period of 2013: , Sales ... , t:slim Pump shipments grew 64 percent to 2,235 pumps ... June 30, 2014 to the same period of 2013: ...
(Date:7/31/2014)... 31, 2014 Nektar Therapeutics (Nasdaq: NKTR ... ended June 30, 2014. Cash and investments ... as compared to $309.1 million at March 31, 2014."The second ... as we look forward to significant milestones for a number ... and Chief Executive Officer of Nektar. "The first of these ...
Breaking Medicine Technology:Sorrento Announces the Unexpected Death of its Chief Business Officer 2Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 2Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 3Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 4Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 5Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 6Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 2Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 3Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 4Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 5Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 6Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 7Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 8Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 9Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 10Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 11Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 12Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 13Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 14
... Invuity, a leading developer of state-of-the-art illuminated surgical ... at the American College of Surgeons, 97th Annual ... specifically for breast mastectomies, lumpectomies, sentinel node biopsies ... proprietary Eigr ™ (pronounced eye-gr) illumination technology ...
... Generex Biotechnology Corporation (OTCBB: GNBT) ( www.generex.com ) announced ... conference call for late November.  The purpose of the ... (i) the status of the Company,s efforts in respect ... subsidiary, Antigen Express, Inc. ( www.antigenexpress.com ), (ii) financing ...
Cached Medicine Technology:Invuity Introduces Advanced Illuminated Surgical System for Breast Procedures 2Invuity Introduces Advanced Illuminated Surgical System for Breast Procedures 3Generex Announces Investor Update Conference Call Planned for Late November 2Generex Announces Investor Update Conference Call Planned for Late November 3
... Oncotype DX™ is a diagnostic assay that ... in women with newly diagnosed, early stage ... disease recurrence, Oncotype DX also assesses the ... assay performed using formalin-fixed, paraffin-embedded tumor ...
... HER2 FISH pharmDx Kit is a direct ... to quantitatively determine HER2 gene amplification in ... amplification is determined from the ratio between ... of the HER2 gene probe (red signals) ...
... age of 3 can choose either the PARI ... design principle applies to both:, ,Maximize aerosol ... output when the patient exhales using two one-way ... leave the nebulizer. The result is a high ...
... breakthrough continuous low-flow nebulizer performance. Patented ... technology allows for optimal medication and ... Heliox). OMNI~NEB takes on severe asthma, ... and critical care situations. Configure with ...
Medicine Products: